CR9923A - Compuestos triciclicos utiles como agonistas de receptores de oxitocina - Google Patents
Compuestos triciclicos utiles como agonistas de receptores de oxitocinaInfo
- Publication number
- CR9923A CR9923A CR9923A CR9923A CR9923A CR 9923 A CR9923 A CR 9923A CR 9923 A CR9923 A CR 9923A CR 9923 A CR9923 A CR 9923A CR 9923 A CR9923 A CR 9923A
- Authority
- CR
- Costa Rica
- Prior art keywords
- oxitocine
- useful
- receptors agonists
- triciclic
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Se describen aqui metodos para tratar y evitar la ansiedad, trastornos relacionados con la ansiedad, esquizofrenia y trastornos relacionados con la esquizofrenia en donde dichos metodos comprenden la administracion de agonistas del receptor de oxitocina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72965605P | 2005-10-24 | 2005-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9923A true CR9923A (es) | 2008-06-27 |
Family
ID=37834124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9923A CR9923A (es) | 2005-10-24 | 2008-04-24 | Compuestos triciclicos utiles como agonistas de receptores de oxitocina |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070117794A1 (es) |
EP (1) | EP1948662A2 (es) |
JP (1) | JP2009512730A (es) |
KR (1) | KR20080063848A (es) |
CN (1) | CN101296929A (es) |
AU (1) | AU2006306547A1 (es) |
BR (1) | BRPI0617770A2 (es) |
CA (1) | CA2626180A1 (es) |
CR (1) | CR9923A (es) |
EC (1) | ECSP088398A (es) |
GT (1) | GT200800052A (es) |
IL (1) | IL190900A0 (es) |
NO (1) | NO20081835L (es) |
RU (1) | RU2008114374A (es) |
WO (1) | WO2007050353A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2954167A1 (fr) | 2009-09-04 | 2011-06-24 | Centre Nat Rech Scient | Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique |
CA2799733A1 (en) | 2010-05-18 | 2011-11-24 | Universite De Geneve | New uses of oxytocin-like molecules and related methods |
WO2011146806A1 (en) * | 2010-05-21 | 2011-11-24 | University Of Florida Research Foundation, Inc. | Methods for reducing anesthetic-inducible epileptogenic and neurotoxic effects |
WO2012016229A2 (en) | 2010-07-30 | 2012-02-02 | The Regents Of The University Of California | Oxytocin treatment to improve memory and modify blood glucose |
WO2016025629A1 (en) | 2014-08-12 | 2016-02-18 | The Regents Of The University Of California | Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues |
EP3328864B1 (en) | 2015-07-06 | 2022-09-07 | Kinoxis Therapeutics Pty Ltd | Therapeutic compounds and compositions for treating social disorders and substance use disorders |
KR102561721B1 (ko) * | 2016-12-12 | 2023-07-28 | 키녹시스 테라퓨틱스 피티와이 리미티드 | 비펩티드성 옥시토신 수용체 작용제 |
CN111867632A (zh) | 2018-03-23 | 2020-10-30 | 赛途公司 | 骨骼肌肥大诱导剂的alk5抑制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900200B2 (en) * | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
GB0120051D0 (en) * | 2001-08-16 | 2001-10-10 | Ferring Bv | Oxytocin agonists |
EP1449844A1 (en) * | 2003-02-14 | 2004-08-25 | Ferring B.V. | benzamide derivatives as oxytocin agonists and vasopressin antagonists |
EP1512687A1 (en) * | 2003-09-05 | 2005-03-09 | Ferring B.V. | Piperazines as oxytocin agonists |
-
2006
- 2006-10-17 EP EP06826053A patent/EP1948662A2/en not_active Withdrawn
- 2006-10-17 CA CA002626180A patent/CA2626180A1/en not_active Abandoned
- 2006-10-17 KR KR1020087012049A patent/KR20080063848A/ko not_active Application Discontinuation
- 2006-10-17 WO PCT/US2006/040425 patent/WO2007050353A2/en active Application Filing
- 2006-10-17 BR BRPI0617770-0A patent/BRPI0617770A2/pt not_active Application Discontinuation
- 2006-10-17 AU AU2006306547A patent/AU2006306547A1/en not_active Abandoned
- 2006-10-17 CN CNA200680039564XA patent/CN101296929A/zh active Pending
- 2006-10-17 JP JP2008537762A patent/JP2009512730A/ja not_active Withdrawn
- 2006-10-17 RU RU2008114374/14A patent/RU2008114374A/ru unknown
- 2006-10-23 US US11/584,995 patent/US20070117794A1/en not_active Abandoned
-
2008
- 2008-04-15 IL IL190900A patent/IL190900A0/en unknown
- 2008-04-16 NO NO20081835A patent/NO20081835L/no not_active Application Discontinuation
- 2008-04-24 GT GT200800052A patent/GT200800052A/es unknown
- 2008-04-24 CR CR9923A patent/CR9923A/es not_active Application Discontinuation
- 2008-04-24 EC EC2008008398A patent/ECSP088398A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007050353A3 (en) | 2007-06-21 |
EP1948662A2 (en) | 2008-07-30 |
WO2007050353A2 (en) | 2007-05-03 |
US20070117794A1 (en) | 2007-05-24 |
AU2006306547A1 (en) | 2007-05-03 |
GT200800052A (es) | 2008-10-06 |
ECSP088398A (es) | 2008-06-30 |
JP2009512730A (ja) | 2009-03-26 |
IL190900A0 (en) | 2008-11-03 |
CN101296929A (zh) | 2008-10-29 |
NO20081835L (no) | 2008-05-20 |
CA2626180A1 (en) | 2007-05-03 |
KR20080063848A (ko) | 2008-07-07 |
RU2008114374A (ru) | 2009-12-10 |
BRPI0617770A2 (pt) | 2011-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9923A (es) | Compuestos triciclicos utiles como agonistas de receptores de oxitocina | |
CL2009000873A1 (es) | Compuestos derivados de ciclohepta[b]piridina, antagonistas del receptor de cgrp; composicion farmaceutica; y uso para el tratamiento de la migrana.b | |
ATE469895T1 (de) | Cgrp-rezeptorantagonisten | |
SV2010003642A (es) | Compuestos | |
CR10872A (es) | Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato | |
SV2010003662A (es) | Derivados de azetidina y ciclobutano como inhibidores de jak ref. x-19081 | |
CL2011002942A1 (es) | Compuestos derivados de 2,4-diamino-pirimidina, agonistas de receptor tipo toll-7 (tlr7); composicion farmaceutica; y su uso para el tratamiento del cancer. | |
ECSP088094A (es) | Antagonistas y agonistas de piperazin-piperidina del receptor 5-ht1a | |
CL2013003731A1 (es) | Compuestos derivados de carboxamida; composición farmacéutica que los comprende, y su uso como inhibidores de la fosfodiesterasa tipo 10a (pde10a) para el tratamiento de trastornos del snc, esquizofrenia, disfunción cognitiva relacionada con la esquizofrenia, trastornos bipolares, depresión, disfunción cognitiva, alteraciones cognitivas, trastornos del comportamiento asociados a la enfermedad de alzheimer, obesidad, enfermedad de huntington y ansiedad. | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
UY34545A (es) | Novedosas dihidropirimidinoisoquinolinonas y composiciones farmacéuticas de las mismas para el tratamiento de trastornos inflamatorios. | |
CR10309A (es) | "compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1" | |
CL2009000171A1 (es) | Compuestos derivados de 1-oxa-3-azaespiro, antagonistas del receptor y5 de neuropeptido y (npy); composicion farmaceutica que comprende dicho compuesto; y uso para el tratamiento de trastornos de la alimentacion, trastornos de la bebida, obesidad y depresion. | |
UY29653A1 (es) | Nuevos anticuerpos anti-madcam | |
CR11621A (es) | Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina | |
ECSP11010974A (es) | Compuestos novedosos como ligandos receptores de canabinoides | |
GT200600081A (es) | Derivados de acetilenno | |
PA8784101A1 (es) | Oxazolidinonas sustituidas y su uso | |
DOP2014000114A (es) | Nuevos 2hindazoles como antagonistas del receptor ep2 | |
EA201290558A1 (ru) | Агонисты mglu2 | |
ECSP088740A (es) | Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios | |
CO6470823A2 (es) | Piperidinas sustituidas | |
ECSP10010379A (es) | Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina | |
CL2007001779A1 (es) | Compuestos triciclicos, con afinidad superior por los receptores de melatonina; composicion farmaceutica; util para la profilaxis o tratamiento de la enfermedad del sueno y compuestos intermediarios. | |
CL2012003539A1 (es) | Compuestos derivados de alquil-piperazino-fenil 4(3h)ona; composicion farmaceutica y su uso para el tratamiento de los trastornos asociados a los receptores serotoninergicos 5-ht1a y 5-ht2a, tales como depresion, ansiedad, y trastornos del sueño. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |